rs2847149

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001071.4(TYMS):​c.455-2701G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.551 in 151,648 control chromosomes in the GnomAD database, including 24,567 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.55 ( 24567 hom., cov: 30)

Consequence

TYMS
NM_001071.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.902

Publications

16 publications found
Variant links:
Genes affected
TYMS (HGNC:12441): (thymidylate synthetase) Thymidylate synthase catalyzes the methylation of deoxyuridylate to deoxythymidylate using, 10-methylenetetrahydrofolate (methylene-THF) as a cofactor. This function maintains the dTMP (thymidine-5-prime monophosphate) pool critical for DNA replication and repair. The enzyme has been of interest as a target for cancer chemotherapeutic agents. It is considered to be the primary site of action for 5-fluorouracil, 5-fluoro-2-prime-deoxyuridine, and some folate analogs. Expression of this gene and that of a naturally occurring antisense transcript, mitochondrial enolase superfamily member 1 (GeneID:55556), vary inversely when cell-growth progresses from late-log to plateau phase. Polymorphisms in this gene may be associated with etiology of neoplasia, including breast cancer, and response to chemotherapy. [provided by RefSeq, Aug 2017]
ENOSF1 (HGNC:30365): (enolase superfamily member 1) This gene can encode a mitochondrial enzyme that is thought to convert L-fuconate to 2-keto-3-deoxy-L-fuconate. This locus was originally identified as the source of antisense RNAs of the adjacent thymidylate synthase gene. Splice variants at this locus may contain an alternate 3' exon that is complementary to the 3'UTR and terminal intron of the thymidylate synthase (TS) RNA and may downregulate TS expression. [provided by RefSeq, Aug 2017]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.768 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TYMSNM_001071.4 linkc.455-2701G>A intron_variant Intron 3 of 6 ENST00000323274.15 NP_001062.1 P04818-1Q53Y97
ENOSF1XM_047437611.1 linkc.-1095C>T 5_prime_UTR_variant Exon 2 of 2 XP_047293567.1
TYMSNM_001354867.2 linkc.454+4051G>A intron_variant Intron 3 of 5 NP_001341796.1
TYMSNM_001354868.2 linkc.206-2701G>A intron_variant Intron 1 of 4 NP_001341797.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TYMSENST00000323274.15 linkc.455-2701G>A intron_variant Intron 3 of 6 1 NM_001071.4 ENSP00000315644.10 P04818-1
TYMSENST00000323224.7 linkc.454+4051G>A intron_variant Intron 3 of 5 1 ENSP00000314727.7 P04818-2
TYMSENST00000323250.9 linkc.206-2701G>A intron_variant Intron 1 of 4 1 ENSP00000314902.5 P04818-3
TYMSENST00000579128.1 linkn.533-2701G>A intron_variant Intron 3 of 3 2

Frequencies

GnomAD3 genomes
AF:
0.550
AC:
83417
AN:
151530
Hom.:
24521
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.775
Gnomad AMI
AF:
0.331
Gnomad AMR
AF:
0.427
Gnomad ASJ
AF:
0.485
Gnomad EAS
AF:
0.684
Gnomad SAS
AF:
0.533
Gnomad FIN
AF:
0.447
Gnomad MID
AF:
0.611
Gnomad NFE
AF:
0.456
Gnomad OTH
AF:
0.542
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.551
AC:
83505
AN:
151648
Hom.:
24567
Cov.:
30
AF XY:
0.549
AC XY:
40706
AN XY:
74086
show subpopulations
African (AFR)
AF:
0.775
AC:
32018
AN:
41322
American (AMR)
AF:
0.427
AC:
6509
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.485
AC:
1682
AN:
3470
East Asian (EAS)
AF:
0.683
AC:
3500
AN:
5124
South Asian (SAS)
AF:
0.531
AC:
2549
AN:
4798
European-Finnish (FIN)
AF:
0.447
AC:
4710
AN:
10534
Middle Eastern (MID)
AF:
0.610
AC:
178
AN:
292
European-Non Finnish (NFE)
AF:
0.456
AC:
30905
AN:
67840
Other (OTH)
AF:
0.547
AC:
1153
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
1525
3050
4575
6100
7625
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
708
1416
2124
2832
3540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.490
Hom.:
24372
Bravo
AF:
0.560
Asia WGS
AF:
0.629
AC:
2189
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.45
DANN
Benign
0.53
PhyloP100
-0.90
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2847149; hg19: chr18-666371; COSMIC: COSV60076327; COSMIC: COSV60076327; API